Thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic Thyroid Cancer
Open Access
- 1 October 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 18 (10) , 1443-1452
Abstract
The thyroid hormone receptor beta (TRβ), a key regulator of cellular growth and differentiation, is frequently dysregulated in cancers. Diminished expression of TRβ is noted in thyroid, breast, and other solid tumors and is correlated with more aggressive disease. Restoration of TRβ levels decreased tumor growth supporting the concept that TRβ could function as a tumor suppressor. Yet, the TRβ tumor suppression transcriptome is not well delineated and the impact of TRβ is unknown in aggressive anaplastic thyroid cancer (ATC). Here, we establish that restoration of TRβ expression in the human ATC cell line SW1736 (SW-TRβ) reduces the aggressive phenotype, decreases cancer stem cell populations and induces cell death in a T3-dependent manner. Transcriptomic analysis of SW-TRβ cells via RNA sequencing revealed distinctive expression patterns induced by ligand-bound TRβ and revealed novel molecular signaling pathways. Of note, liganded TRβ repressed multiple nodes in the PI3K/AKT pathway, induced expression of thyroid differentiation markers, and promoted proapoptotic pathways. Our results further revealed the JAK1–STAT1 pathway as a novel, T3-mediated, antitumorigenic pathway that can be activated in additional ATC lines. These findings elucidate a TRβ-driven tumor suppression transcriptomic signature, highlight unexplored therapeutic options for ATC, and support TRβ activation as a promising therapeutic option in cancers. Implications: TRβ-T3 induced a less aggressive phenotype and tumor suppression program in anaplastic thyroid cancer cells revealing new potential therapeutic targets.Keywords
All Related Versions
Funding Information
- NIH (U54 GM115516)
- NCI (1F99CA245796-01)
- UVM (12577-21)
- NCI (P30CA046934)
This publication has 50 references indexed in Scilit:
- Inhibition of Tumorigenesis by the Thyroid Hormone Receptor β in Xenograft ModelsThyroid®, 2014
- Molecular pathogenesis and mechanisms of thyroid cancerNature Reviews Cancer, 2013
- Treatment of Mycoplasma Contamination in Cell Cultures with PlasmocinJournal of Biomedicine and Biotechnology, 2012
- Tumor Suppressor Action of Liganded Thyroid Hormone Receptor β by Direct Repression of β-Catenin Gene ExpressionEndocrinology, 2010
- ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experimentsBioinformatics, 2010
- Hypothyroidism Enhances Tumor Invasiveness and Metastasis DevelopmentPLOS ONE, 2009
- Regulation of β-Catenin by a Novel Nongenomic Action of Thyroid Hormone β ReceptorMolecular and Cellular Biology, 2008
- Thyroid hormone receptor-β (TRβ1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2Oncogene, 2007
- A Small-Molecule Enhancer of Signal Transducer and Activator of Transcription 1 Transcriptional Activity Accentuates the Antiproliferative Effects of IFN-γ in Human Cancer CellsCancer Research, 2007
- Mice with a Mutation in the Thyroid Hormone Receptor β Gene Spontaneously Develop Thyroid Carcinoma: A Mouse Model of Thyroid CarcinogenesisThyroid®, 2002